Skip to content
back
blood-plasma-header

Blood plasma fractionation for efficient resource use

Manage blood plasma fractionation with integrated systems that align process steps, quality and efficiency.

Connect with our experts Downloads

Blood plasma fractionation equipment for complex process chains

Managing limited plasma supply, process integration and quality control adds complexity to blood plasma fractionation equipment decisions.

As your strategic lifecycle partner, Syntegon connects fractionation, purification, formulation, automation and key utility systems to manage interfaces and keep execution aligned.

Better yield, lower complexity, safer plasma processing

How to manage interfaces across plasma fractionation?

Keep complex process steps aligned under one partner.

How to improve efficiency in custom plasma projects?

Keep custom process steps aligned from the start.

How to strengthen quality and patient safety?

Build process control into every critical step.

Blood plasma fractionation equipment across the full process chain

blood-plasma-hotspot

Thawing and fractionation

Control the first process steps to reduce handoffs early and create a stable basis for downstream purification.

Purification and formulation

Connect purification and formulation to protect recovery and prepare the product to transfer to fill-finish. 

Filling and closing

Move into fill-finish with precise dosing and gentle container handling to protect product quality. 

 

Freeze drying

Add lyophilization for sensitive products that require extended stability and reliable downstream handling. 

Pasteurization

Apply controlled heat treatment where required to support product safety and a robust control strategy.
Sterilization solutions  

Inspection

Use automated inspection to detect container or product defects early and strengthen batch release readiness. 

Pure Media

Prepares and supplies purified process media – including buffers and WFI – to keep fractionation steps running within validated parameters.

blood-plasma-hotspot

Thawing and fractionation

Control the first process steps to reduce handoffs early and create a stable basis for downstream purification.

blood-plasma-hotspot

Purification and formulation

Connect purification and formulation to protect recovery and prepare the product to transfer to fill-finish. 

blood-plasma-hotspot

Filling and closing

Move into fill-finish with precise dosing and gentle container handling to protect product quality. 

 

blood-plasma-hotspot

Freeze drying

Add lyophilization for sensitive products that require extended stability and reliable downstream handling. 

blood-plasma-hotspot

Pasteurization

Apply controlled heat treatment where required to support product safety and a robust control strategy.
Sterilization solutions  

blood-plasma-hotspot

Inspection

Use automated inspection to detect container or product defects early and strengthen batch release readiness. 

blood-plasma-hotspot

Pure Media

Prepares and supplies purified process media – including buffers and WFI – to keep fractionation steps running within validated parameters.

Explore the complete line

Thawing and fractionation
Purification and formulation
Pasteurization
Filling and closing
Freeze drying
Inspection
Service

Blood plasma fractionation equipment across the full process chain

customization1_11

Custom and modular solutions from thawing to formulation

Reduce interfaces across a highly customized plasma process.
process

Inactivation and purification built into the process

Protect product quality through controlled critical steps.
automation

Fully integrated and automated system design

Run complex processing steps with less coordination effort.
RZ_Grafik_Blood_plasma_components_RGB

What makes blood plasma such a valuable product?

SYNTEGON_IC_ARROW_TREND_GRN_FRAME
Rising global demand

Globally rising demand for plasma derivatives through an increase in immune diseases, coagulation disorders, and genetic defects.

SYNTEGON_IC_DROP_GRN_FRAME
Endogenous

Plasma is largely generated by the body itself and is difficult to produce chemically or biopharmaceutically.

SYNTEGON_IC_HEART_GRN_FRAME
Donor shortage

Up to 1,000 donations are required to treat one patient for one year.

SYNTEGON_IC_CLOCK_GRN_FRAME
Temporal aspects

Time-consuming: production of plasma derivatives takes between 7 and 12 months.

SYNTEGON_IC_CURRENCY_DOLLAR_GRN_FRAME
Financial aspects

Collecting plasma is time-consuming and expensive.

Your strategic lifecycle partner for blood plasma fractionation

service-life-cycle
Ready for everything from startup to stable production

From installation to optimization, Syntegon supports you with structured service packages, training, and specialists – for safe, stable and resilient production across the lifecycle.

Learn more
service-life-uptime
Secure availability – every day

Fast spare parts, qualified support and preventive maintenance help you avoid unplanned downtime, protect performance and keep daily operations reliable.

Learn more
service-future-ready
Make your line fit for tomorrow

Scalable retrofits, data solutions and handling/automation systems help you adapt to new demands, improve OEE and keep your lines future-proof across changing requirements.

Learn more

Frequently asked questions

Blood plasma fractionation is a multi-step manufacturing process that separates plasma into specific protein fractions for further purification and formulation. It typically includes pooling and thawing, basic fractionation, purification, formulation, and the supporting utility and cleaning systems. 

Blood plasma fractionation can produce therapies and proteins such as albumin, immunoglobulins, fibrinogen, Factor VIII, von Willebrand factor, prothrombin complex factors, alpha 1-antitrypsin, and antithrombin III. The exact product mix depends on the process design and the manufacturer’s portfolio. 

It combines multiple tightly linked process steps, critical quality controls, utilities, cleaning systems, and automation within one production chain. Complexity rises further when custom engineering and third-party unit operations must work together without creating interface risks. 
 

Integrated process design reduces handoffs between fractionation, purification, formulation, utilities, and automation. This makes projects easier to execute and gives teams stronger control over efficiency, product quality, and patient safety. 

They are critical process stages used to protect product quality and patient safety before final formulation. Their performance also depends on the surrounding systems, including buffer preparation, cleaning concepts, and overall process integration. 

It becomes important when specific purification or separation steps require specialized unit operations outside the core process scope. In these cases, strong integration reduces interface gaps and helps keep the wider process concept aligned. 
 

Look for end-to-end process understanding, custom and modular engineering capability, integration of utilities and automation, and experience with third-party modules. It is also important to choose a partner that can support quality-focused design, reliable project execution, and lifecycle needs after start-up. 

Lifecycle services reduce risk by improving uptime, keeping maintenance structured, and making support easier to access when production issues arise. They also help teams adapt equipment and processes as operational needs change over time. 

Interested in blood plasma fractionation?

Interested in blood plasma fractionation?

Talk to a Syntegon expert to learn more about blood plasma fractionation.

Learn more

News

Automatic tray loading for safe pharmaceuticals

Discover our automatic tray loading machines. Enhance output, ensure flexible format changes, and protect sensitive containers.

Sustainability with sterilizers by Syntegon

Discover how Syntegon partners with pharmaceutical companies to balance sustainability, efficiency, and profitability in a highly regulated industry.

Syntegon supports OSD manufacturing education

Discover how Syntegon enhances pharmaceutical education with Dr. Marcus Knöll's insights at the University of Maryland's Tablets and Capsules Short Course.